Vasily Ignatiev, CEO of R-Pharm, re-elected as the Vice Chairman of the Board of Directors of AIPM

February 26, 2020, Moscow – The Association of International Pharmaceutical Manufacturers (AIPM) announces that Board of Directors has confirmed the authority of Vasily Ignatiev, CEO of R-Pharm, as Vice Chairman of the AIPM Board of Directors for the second term.

 Mr. Ignatiev has worked in the pharmaceutical industry for over 20 years. He has earned extensive experience in various positions at some major international pharmaceutical companies that operate on the Russian market. In 2008 Mr. Ignatiev joined R-Pharm and currently holds the CEO position in the company, which became a member of the Association of International Pharmaceutical Manufacturers in 2013. He was elected the Vice Chairman of the Board of Directors of AIPM for the first time in February 2018.

"First and foremost, I would like to thank the Board of Directors of AIPM for their confidence in me. It is an honor to be able to enact the values ​​and strategic priorities of the Association. I assure that the R-Pharm Group of companies’ mission is driven by the same basic principles as the mission of the Association. Together with other AIPM member companies, we have come a long way and have done a lot to develop the market, expand the range of medicines, and increase their availability. Hundreds of innovative drugs are localized in the Russian Federation and entirely new therapeutic fields are developing. But more work lies ahead of us. It's important to stay united and continue in the same spirit. This will enable the members of the Association of International Pharmaceutical Manufacturers to achieve the most important social goal of improving the quality of life and life expectancy of millions of people," - said Vasily Ignatiev, CEO of R-Pharm, Vice Chairman of the Board of Directors of AIPM.

"The re-election of Vasily Ignatiev unequivocally confirms the Association’s commitment to improving the availability of modern, effective, safe and high-quality medicines to patients in the Russian Federation. AIPM will continue to be a reliable partner to the state, the medical and patient communities in the search for optimal healthcare solutions and the implementation of innovations in strict compliance with intellectual property rights and ethical standards of self-regulation. We will also continue to promote transparency and predictability on the Russian pharmaceutical market. Vasily Ignatiev is consistent in representing a balanced professional position in the industry, so there is strong reasons behind that his mandate has been extended for another two years," - said Vladimir Shipkov, Executive Director of AIPM.

About:

The Association of International Pharmaceutical Manufacturers (AIPM) was established in 1994 to represent leading international pharmaceutical companies operating within Russia. Its members produce and develop modern, effective, safe and high-quality medicines. AIPM unites 60 international companies, which account for over 80% of the world's pharmaceutical production and over 60% of the volume of medicines supplied to the Russian Federation.

For more information, please contact 

Elena Yankovskaya, Head of Communications, AIPM

Tel.: +7 (495) 933 70 40 (ext. 109), E.Yankovskaya@aipm.org